Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
In a recently accepted manuscript titled “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data”, scientists from Insilico ...
Hosted on MSN
AI is helping doctors repurpose old drugs for new cures: 'The solution is in your neighborhood pharmacy'
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
The collaboration will combine Syngene’s preclinical development expertise with VivaMed's AI-generated therapeutic hypotheses.
Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.
The study in brief: Cancer research//Basic research//Peer review publication//Researcher-initiated study//Computer simulation//Animal study//In vitro/In vivo//In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results